Pharmafile Logo
Pharmafocus logo
Advanced Search

pioglitazone

Showing 3 posts of 3 posts found.

Actos image

Takeda pays $2.7 billion to settle Actos lawsuits

May 1, 2015
Sales and Marketing Actos, FDA, Takeda, bladder, lilly, pioglitazone, type 2

Takeda has agreed to pay $2.7 billion to finally settle thousands of US lawsuits claiming its diabetes drug Actos can …

News
Actos image

Takeda offers $2.2 billion to resolve Actos damages claims

April 1, 2015
Sales and Marketing Actos, Cancer, Takeda, bladder, diabetes, heart, pioglitazone

Takeda has attempted to settle its hefty damages bill over claims it was hiding cancer risks in its diabetes drug …

News
Actos image

Analysis finds no Actos bladder cancer link

December 8, 2014
Sales and Marketing Actos, Cancer, Takeda, bladder, lilly, pioglitazone, type 2

A large-scale analysis of patient data has found that pioglitazone, the diabetes drug that is the subject of ongoing safety …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025